Quest Diagnostics (DGX)
(Delayed Data from NYSE)
$146.01 USD
-0.83 (-0.57%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $143.59 -2.42 (-1.66%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/23/2024
Time: BMO |
6/2024 | $2.31 | -0.72% |
Earnings Summary
For their last quarter, Quest Diagnostics (DGX) reported earnings of $2.04 per share, beating the Zacks Consensus Estimate of $1.86 per share. This reflects a positive earnings surprise of 9.68%. Look out for DGX's next earnings release on July 23, 2024. For the next earning release, we expect the company to report earnings of $2.31 per share, reflecting a year-over-year increase of .43%.
Earnings History
Price & Consensus
Zacks News for DGX
Edwards Lifesciences (EW) Buys Innovalve to Boost TMVR Solutions
DGX: What are Zacks experts saying now?
Zacks Private Portfolio Services